Taken together, the present study sheds new light on the role of individual HDAC in the activation of immune cells and appoints HDAC5 as a potential therapeutic target in diseases with massive macrophage activation like modulated as in autoimmune diseases or inflammation-associated cancer. Here, HDAC5 is linked to cancer.